Sean Duffy was named Chief Executive Officer of Omada Health, Inc., effective January 1, 2027. As of November 6, 2026, Omada Health, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on August 6, 2026, naming 1 appointment (Form 8-K, August 6, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Omada Health, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Omada Health, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-08-06. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Omada Health, Inc. files it.
Also on the record for Omada Health, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 5, 2026 | Stake report, Schedule 13G/A, by FMR LLC | 4.6% of the class | 5%+ stakes | Source |
| November 2, 2026 | Stake report, Schedule 13G/A, by Revelation Alpine, LLC | — | 5%+ stakes | Source |
| October 27, 2026 | Stake report, Schedule 13G, by BlackRock, Inc. | 6% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G, by American Century Investment Management, Inc. | 6.2% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by Divisadero Street Capital Management, LP | 6.3% of the class | 5%+ stakes | Source |
| June 23, 2026 | Stake report, Schedule 13G, by The Cigna Group | 5.8% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G, by Divisadero Street Capital Management, LP | 9.9% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by Benjamin A. Horowitz | 4.2% of the class | 5%+ stakes | Source |
| May 6, 2026 | Stake report, Schedule 13G/A, by FMR LLC | 5.6% of the class | 5%+ stakes | Source |
| March 2, 2026 | Stake report, Schedule 13G, by Divisadero Street Capital Management, LP | 8.7% of the class | 5%+ stakes | Source |
| February 17, 2026 | Stake report, Schedule 13G/A, by Casey M Tansey | 0.2% of the class | 5%+ stakes | Source |
| February 17, 2026 | Stake report, Schedule 13G/A, by Marc L. Andreessen | 6.1% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Omada Health, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Omada Health, Inc. and the records around it.
Omada Health, Inc. elsewhere on the record
- 5%+ stake filings Nov 2026
- Who owns it
Companies that share a holder
- Andreessen Horowitz Fund IV, L.P. also filed stake reports on 1 other company: SAMSARA INC. (Sep 2025)
- Divisadero Street Capital Management, LP also filed stake reports on 22 other companies: Rush Street Interactive, Inc. (Sep 2026), Build-a-Bear Workshop, Inc (Aug 2026), Citi Trends, Inc. (Aug 2026)
- American Century Investment Management, Inc. also filed stake reports on 83 other companies: Visteon Corporation (Oct 2026), MarineMax, Inc. (Sep 2026), AdvanSix Inc. (Aug 2026)
Watch Omada Health, Inc.
Get an email when Omada Health, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Omada Health, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Omada Health, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Omada Health, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 20 records.
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-08-06 | In | Chief Executive Officer | 2027-01-01 | 8-K, 2026-08-06 |
Who leads Omada Health, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Executive Officer: Sean Duffy, appointed, effective 2027-01-01 (filed 2026-08-06).
New leaders reset buying decisions — get the Full Report on Omada Health, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Executive Officer at Omada Health, Inc., with the record behind each one.
Find candidates like Chief Executive Officer at Omada Health, Inc.Every change, in the filing's words
Appointed: Sean Duffy, Chief Executive Officer, effective 2027-01-01
Leadership Transition On August 6, 2026, the Company announced that Sean Duffy, the Company's current Chief Executive Officer, will become the Company's Executive Chairman of the Board of Directors (the "Board"), and Wei-Li Shao, the Company's current President, will succeed Mr. Duffy as the Company's Chief Executive Officer (the "Leadership Transition") effective January 1, 2027 (the "Transition Date").
- The Leadership Transition was approved by the Board on August 5, 2026.
- Each of Mr. Duffy and Mr. Shao will continue to serve in their current roles through the Transition Date.
- In connection with the Leadership Transition, on August 5, 2026, the Board also approved the appointment of Mr. Shao as a Class I director, effective as of the Transition Date, to serve for a term expiring at the 2029 Annual Meeting of Stockholders and until his successor is elected and qualified or until his earlier death, resignation or removal.
- The Board has not yet approved any compensation changes in connection with the Leadership Transition.
- Appointment of Lead Independent Director On August 5, 2026, the Board approved the appointment of Jeryl Hilleman as Lead Independent Director, effective as of the Transition Date.
- Ms. Hilleman will continue to serve as the Chairperson of the Board through the Transition Date.
Tools for this story
Each opens in a new tab, filled in for Omada Health, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.